{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:50:38Z","timestamp":1790819438728,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ejca.2009.11.002","type":"journal-article","created":{"date-parts":[[2009,12,12]],"date-time":"2009-12-12T06:17:01Z","timestamp":1260598621000},"page":"616-624","source":"Crossref","is-referenced-by-count":36,"title":["COX-2 expression in chondrosarcoma: A role for celecoxib treatment?"],"prefix":"10.1016","volume":"46","author":[{"given":"Y.M.","family":"Schrage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Briaire-de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.E.","family":"van den Akker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.M.","family":"Taminiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kalinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Llombart-Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.V.M.G.","family":"Bov\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2009.11.002_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B","article-title":"Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading","volume":"40","author":"Evans","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2009.11.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002560050466","article-title":"Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. II. Juxtacortical cartilage tumors.","volume":"28","author":"Brien","year":"1999","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.ejca.2009.11.002_bib3","series-title":"World Health Organisation classification of tumours. Pathology and genetics of tumours of soft tissue and bone","first-page":"247","article-title":"Chondrosarcoma","author":"Bertoni","year":"2002"},{"key":"10.1016\/j.ejca.2009.11.002_bib4","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone","first-page":"237","article-title":"Chondromas: enchondroma, periosteal chondroma, and enchondromatosis","author":"Lucas","year":"2002"},{"key":"10.1016\/j.ejca.2009.11.002_bib5","first-page":"23","article-title":"Dyschondroplasie","volume":"93","author":"Ollier","year":"1900","journal-title":"Lyon Med"},{"key":"10.1016\/j.ejca.2009.11.002_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2106\/00004623-198769020-00016","article-title":"The malignant potential of enchondromatosis","volume":"69","author":"Schwartz","year":"1987","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.ejca.2009.11.002_bib7","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2009.11.002_bib8","first-page":"78","article-title":"Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis","volume":"6","author":"van Stolk","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2009.11.002_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2009.11.002_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0163-7258(91)90054-P","article-title":"Prostaglandin and thromboxane biosynthesis","volume":"49","author":"Smith","year":"1991","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ejca.2009.11.002_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.humpath.2005.12.001","article-title":"Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas","volume":"37","author":"Endo","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejca.2009.11.002_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000078327","article-title":"Cyclooxygenase-2 expression in chondrosarcoma","volume":"66","author":"Sutton","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2009.11.002_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<237::AID-GCC8>3.0.CO;2-L","article-title":"Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma","volume":"26","author":"Bov\u00e9e","year":"1999","journal-title":"Genes Chrom Cancer"},{"key":"10.1016\/j.ejca.2009.11.002_bib14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jcp.54.10.778","article-title":"High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma","volume":"54","author":"Baelde","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejca.2009.11.002_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/path.2008","article-title":"Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog (IHH) signalling","volume":"209","author":"Hameetman","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2009.11.002_bib16","first-page":"3","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"10.1016\/j.ejca.2009.11.002_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/01.LAB.0000073131.34648.EA","article-title":"Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: comparative histologic and genetic studies with its tumor of origin","volume":"83","author":"Gil-Benso","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejca.2009.11.002_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1","article-title":"A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation","volume":"77","author":"Kunisada","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2009.11.002_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00428-004-1194-y","article-title":"Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier\u2019s disease","volume":"446","author":"Kalinski","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejca.2009.11.002_bib20","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1158\/1078-0432.CCR-05-1253","article-title":"Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma","volume":"11","author":"Cleton-Jansen","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2009.11.002_bib21","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1158\/0008-5472.CAN-08-4801","article-title":"Kinome profiling of chondrosarcoma reveals Src-pathway activity and dasatinib as option for treatment","volume":"69","author":"Schrage","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2009.11.002_bib22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00280-007-0668-4","article-title":"Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer","volume":"62","author":"de Heer","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ejca.2009.11.002_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djj206","article-title":"Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors","volume":"98","author":"Grosch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2009.11.002_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.steroids.2007.09.011","article-title":"Suppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition","volume":"73","author":"Su","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.ejca.2009.11.002_bib25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2009.11.002_bib26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2009.11.002_bib27","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2165\/00003495-200767160-00008","article-title":"Celecoxib: a review of its use in the management of arthritis and acute pain","volume":"67","author":"Frampton","year":"2007","journal-title":"Drugs"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804909008399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804909008399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T13:20:53Z","timestamp":1544793653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804909008399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0959804909008399"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2009.11.002","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}